🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mario L. Marques‐Piubelli

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-6324-2096
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995
Top 100%
0DataRank
Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy”.

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy

Nature Communications(2021)10.1038/s41467-021-26282-z
N/A
0DataRank · unranked
132 citations

Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin S. Im, Patrick K. Reville +28 more

Cutaneous Toxicities in the Setting of Immune Checkpoint Blockade:

Surgical pathology clinics(2021)10.1016/j.path.2021.01.002
N/A
0DataRank · unranked
5 citations

Susan Y. Chon, Mario L. Marques‐Piubelli, Emily Y. Chu, Jonathan L. Curry

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

Journal of Clinical Investigation(2022)10.1172/jci159402
N/A
0DataRank · unranked
58 citations

Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan Bandey, Jay R T. Adolacion +13 more

Single-cell immune mapping of adenoid cystic carcinoma (ACC) reveals potential therapeutic targets for the aggressive solid subtype.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6090
N/A
0DataRank · unranked
5 citations

Felippe Lazar Neto, Daniel J. McGrail, Kaiyi Li, Mario L. Marques‐Piubelli, Sammy Ferri‐Borgogno +8 more

Multiomics profiling and association with molecular and immune features in association with benefits from immunotherapy for patients with previously treated stage IV or recurrent squamous cell lung cancer from the phase III SWOG LungMAP S1400I trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9046
N/A
0DataRank · unranked
0 citations

Dzifa Y. Duose, Jiexin Zhang, Mary W. Redman, Rossana Lazcano Segura, Mario L. Marques‐Piubelli +14 more

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995
Top 100%
0DataRank
Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6096
N/A
0DataRank · unranked
0 citations

Daniel J. McGrail, Simon Heeke, Luana Guimarães de Sousa, Kaiyi Li, Diana Bell +8 more

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-0251
N/A
0DataRank · unranked
42 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1
Top 100%
0DataRank
Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.6104
N/A
0DataRank · unranked
0 citations

Daniel J. McGrail, Yoshitsugu Mitani, Simon Heeke, Luana Guimarães de Sousa, Erison Santos +8 more